Moreover, in the AOM/DSS CRC model, Dnase1l3 deficiency exacerbated early-phase inflammation that was associated with diminished type I IFN response, and this further led to reduced T cell accumulation and enhanced tumor formation at the later stage (Figure 3 and Supplemental Figure 5). The gene discussed is DNASE1L3; the disease is neoplasm.